Anna Jerzak vel Dobosz

Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors

Jerzy Lasota, Anna Jerzak vel Dobosz, Bartosz Wasąg et al. · Laboratory Investigation · 2007 · 92 citations · Full text

Tumor Biology, Oncology, Somatic Variant +14

Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs)

Piotr Rutkowski, Zbigniew Nowecki, Maria Dȩbiec‐Rychter et al. · Journal of Cancer Research and Clinical Oncology · 2007 · 53 citations · Full text

Imatinib Therapy, Long-term Effects, Gastrointestinal Oncology +9

Functional features of gene expression profiles differentiating gastrointestinal stromal tumours according to KITmutations and expression

Jerzy Ostrowski, Marcin Polkowski, Agnieszka Paziewska et al. · BMC Cancer · 2009 · 31 citations · Full text

What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?

Piotr Rutkowski, Jolanta Andrzejuk, Elżbieta Bylina et al. · Medical Oncology · 2013 · 29 citations · Full text

Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.

Piotr Rutkowski, Maria Dêbiec‐Rychter, Zbigniew Nowecki et al. · PubMed · 2007 · 17 citations